0000899243-22-017091.txt : 20220506
0000899243-22-017091.hdr.sgml : 20220506
20220506161515
ACCESSION NUMBER: 0000899243-22-017091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220504
FILED AS OF DATE: 20220506
DATE AS OF CHANGE: 20220506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yu Debra
CENTRAL INDEX KEY: 0001869480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40947
FILM NUMBER: 22901230
MAIL ADDRESS:
STREET 1: C/O PERCEPTIVE ADVISORS
STREET 2: 51 ASTOR PLACE, 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LianBio
CENTRAL INDEX KEY: 0001831283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 486-2308
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-04
0
0001831283
LianBio
LIAN
0001869480
Yu Debra
C/O LIANBIO
103 CARNEGIE CENTER DRIVE, SUITE 309
PRINCETON
NJ
08540
0
1
0
0
See Remarks
Ordinary Shares
2022-05-04
4
M
0
1000000
1.71
A
1000000
D
Stock Option (Right to Buy)
1.71
2022-05-04
4
M
0
1000000
0.00
D
2030-01-01
Ordinary Shares
1000000
999947
D
1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.
President & Chief Strategy Officer
By: /s/ Angela Chen, Attorney-in-Fact
2022-05-06